Inspiratory Support Improves Preoxygenation in Healthy Subjects
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Preoxygenation optimizes oxygen content in the functional residual capacity (FRC). Adequate preoxygenation is defined by an expiratory oxygen fraction (FEO2) > 90%. Inspiratory support and positive end expiratory pressure (PEEP) can create a better reservoir, improve gas exchange and shorten the time needed for adequate preoxygenation. The goal of the study is to evaluate the efficacy and tolerability of different levels of inspiratory support and positive end expiratory pressure during preoxygenation in healthy subjects.
| Condition | Intervention |
|---|---|
|
Healthy |
Other: VS Other: AI-4/PEEP-4 Other: AI-6/PEEP-4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) |
| Official Title: | The Efficacy and Tolerability of Different Levels of Inspiratory Support and PEEP During Preoxygenation. A Randomized Controlled Trial. |
- expiratory oxygen fraction (end-tidal 02) [ Designated as safety issue: Yes ]
- inspiratory oxygen fraction [ Designated as safety issue: Yes ]
- end-tidal CO2 [ Designated as safety issue: Yes ]
- tidal volume [ Designated as safety issue: Yes ]
- inspiratory pressure [ Designated as safety issue: Yes ]
- subject's tolerance [ Designated as safety issue: Yes ]
- leaks around the mask during preoxygenation [ Designated as safety issue: Yes ]
- minute volume [ Designated as safety issue: Yes ]
- endexpiratory pressure [ Designated as safety issue: Yes ]
| Enrollment: | 20 |
| Study Start Date: | February 2007 |
| Study Completion Date: | September 2007 |
| Primary Completion Date: | September 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: BiPAP6 assisted preoxygenation |
Other: AI-6/PEEP-4
Spontaneous breathing of 100% oxygen in a facemask with application of an inspiratory pressure of 6 cm H2O and a positive end-expiratory pressure of 4 cm H2O, for 3 minutes.
|
| Active Comparator: BiPAP4 assisted preoxygenation |
Other: AI-4/PEEP-4
Spontaneous breathing of 100% oxygen in a facemask with application of an inspiratory pressure of 4 cm H2O and a positive end-expiratory pressure of 4 cm H2O, for 3 minutes
|
| Active Comparator: Standard preoxygenation (VS) |
Other: VS
Spontaneous breathing of 100% oxygen in a facemask for 3 minutes
|
Detailed Description:
We conducted a double blind prospective randomized trial on 20 healthy volunteers. Each subject went through three modes of preoxygenation in random order: normal breathing (SP), breathing under inspiratory support 4 cmH2O/PEEP 4 cmH2O (PSM-4) and inspiratory support 6 cmH2O /PEEP 4 cmH2O (PSM-6). Each mode lasted for 3 min and parameters were recorded every 10 s. We evaluated subject's tolerance, leaks and easiness of each mode of preoxygenation according to a simplified (1 to 4) scale. Two-way ANOVA was used to compare FEO2 while simple ANOVA was used for time to reach FEO2=90%.
Eligibility| Ages Eligible for Study: | 20 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy volunteers
- Aged between 20 to 40 years
Exclusion Criteria:
- Body mass index > 30
- Mustache, beard
- Claustrophobia
Contacts and Locations| Canada, Quebec | |
| Maisonneuve Rosemont Hospital | |
| Montreal, Quebec, Canada, H1T 2M4 | |
| Principal Investigator: | Issam Tanoubi, M.D. | Maisonneuve Rosemont Hospital, University Of Montreal |
| Study Director: | François Donati, PhD, MD, FRCPC | Maisonneuve Rosemont Hospital, University Of Montreal |
| Study Chair: | Pierre Drolet, MD, FRCPC | Maisonneuve Rosemont Hospital, University Of Montreal |
| Principal Investigator: | Louis Phillipe Fortier, MSc, MD, FRCPC | Maisonneuve Rosemont Hospital, University Of Montreal |
More Information
Additional Information:
Publications:
| Responsible Party: | Tanoubi Issam, M.D., Maisonneuve-Rosemont Hospital, Department Of Anesthesiology |
| ClinicalTrials.gov Identifier: | NCT00922753 History of Changes |
| Other Study ID Numbers: | 06109 |
| Study First Received: | June 16, 2009 |
| Last Updated: | June 17, 2009 |
| Health Authority: | Canada: Health Canada Canada: Canadian Institutes of Health Research Canada: Ethics Review Committee |
Keywords provided by Maisonneuve-Rosemont Hospital:
|
Preoxygenation Inspiratory Support Healthy EndtidalO2 |
Additional relevant MeSH terms:
|
Respiratory Aspiration Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013